ARNA Intraday Update: Shareholders Exiting (ARNA)

Arena Pharma

last price check is $1.89, down 7.35% after the announcement today; the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application.